Announcements Trials
Browse Landscape

Phase

Phase 2 66Phase 1 26Phase 1/2 11Phase NA 10Phase 3 10Phase 2/3 3Phase 4 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 10Other hematologic neoplasm 5CNS 4Head & Neck 3Genitourinary 3Gastrointestinal 3Thoracic 2Myeloid 1Breast 1

Conditions

Head and Neck Neoplasms 32Squamous Cell Carcinoma of Head and Neck 24Mouth Neoplasms 11Nasopharyngeal Carcinoma 10Thyroid Neoplasms 9Oropharyngeal Neoplasms 9Laryngeal Neoplasms 8Ovarian Neoplasms 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Colorectal Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Melanoma 4Carcinoma, Squamous Cell 4Carcinoma 4Thyroid Carcinoma, Anaplastic 3Thyroid Cancer, Papillary 3Recurrence 3Neoplasms, Squamous Cell 3Nasopharyngeal Neoplasms 3Hematologic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Stomatitis 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Parathyroid Neoplasms 2

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Recurrence × Head & Neck × Clear all
NCT04534205 2026-05-22

AHEAD-MERIT

BioNTech SE

Phase 2/3 Recruiting
350 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06719479 2024-12-05

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

SUNHO(China)BioPharmaceutical CO., Ltd.

Phase 2/3 Not yet recruiting
60 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT06241599 2024-02-05

A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Sun Yat-sen University

Phase 2/3 Recruiting
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡